If you really want to call yourself a counter investor, it’s time to take a closer look at what hasn’t worked so far this year: value stocks and dividend stocks. Value stocks have underperformed growth stocks (especially Tesla Inc. TSLA, -4.09% and the most popular tech names) amid the economic …
Read More »
Text size Spencer Platt / Getty Images Large pharmaceutical company Pfizer announced second-quarter financial results on Tuesday morning that exceeded Wall Street expectations, sending shares of around 3% in pre-trade. The company reported earnings of $ 0.78 per share, beating the FactSet consensus at $ 0.10 and the S&P Capital …
Read More »
Text size Albert Bourla, CEO of the pharmaceutical company Pfizer Drew Angerer / Getty Images Albert Bourla, Pfizer‘s CEO, he has no patience with the argument that pharmaceutical companies should not make a profit from the drugs and vaccines they introduce to fight Covid-19. “I think it is very bad,” …
Read More »
Pfizer (PFE) – Get report On Tuesday it was receiving a solid boost, more than 4% after the company’s better-than-expected earnings report. The company reported second-quarter earnings of 78 cents a share, beating estimates by 12 cents. Revenue of $ 11.8 billion sank 11% year-over-year, but exceeded estimates by $ …
Read More »
Text size Photograph by JOSEPH PREZIOSO / AFP via Getty Images The Modern biotechnology company, which has received commitments of nearly $ 1 billion from the federal government to develop its Covid-19 vaccine, seeks to sell the vaccine for between $ 25 and $ 30 per dose, the Financial Times …
Read More »